TOKYO--(BUSINESS WIRE)--PeptiDream Inc., a public Tokyo-based biopharmaceutical company (“PeptiDream”)(TOKYO:4587) announced today that Swiss-based Novartis has exercised its option under their 2012 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback